Compare Wegovy vs Mounjaro Pricing and Mechanisms
Why Consider Switching From Wegovy To Mounjaro Based On UK Pricing
When evaluating switching from Wegovy to Mounjaro, cost considerations often influence treatment decisions alongside clinical factors. EverydayMeds provides transparent pricing for both medications, ensuring patients can make informed choices without hidden fees or consultation charges. Our Wegovy single pen prices range from £79.99 for the 0.25mg starter dose to £209.99 for the 2.4mg maintenance dose, with discount codes FIRST40 (new patients) and DOSE25 (returning patients) applied at checkout.
The decision between these prescription-only medicines should balance mechanism differences, dosing schedules, and overall treatment costs. Mounjaro (tirzepatide) operates as a dual GIP and GLP-1 receptor agonist, whilst Wegovy (semaglutide) targets GLP-1 pathways exclusively. Both require gradual dose escalation over 16-20 weeks, making pricing comparison across the full treatment journey essential for budget planning.
Complete Wegovy Pricing Structure For Switching From Wegovy To Mounjaro Comparison
Our comprehensive Wegovy pricing ensures no surprises during your treatment journey, with bundle options providing convenient multi-month supply arrangements. Single pen pricing includes: 0.25mg starter dose £79.99, 0.5mg escalation £94.99, 1mg continuation £99.99, 1.7mg progression £139.99, and 2.4mg maintenance £209.99. Getting Started bundles like the Intro Duo (0.25mg & 0.5mg) cost £169.99, whilst the Progress Trio (0.5mg, 1mg & 1.7mg) provides three months' supply for £369.99.
Consistency bundles offer same-dose supplies for patients maintaining stable dosing schedules, such as Consistency 2.4mg (×2 pens) for £419.99 or the Ultimate Stability Trio (2.4mg ×3) for £649.99. All prices include clinical assessment, prescriber review, and next-day cold-chain delivery through our GPhC-registered service (#9012878). Discount codes are applied automatically at checkout, ensuring the listed prices reflect your final payment amount.
Clinical Evidence When Switching From Wegovy To Mounjaro Considerations
In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in the STEP 1 study (Wilding et al., NEJM, 2021). The STEP trial programme demonstrated consistent efficacy across different patient populations, including those with type 2 diabetes and cardiovascular risk factors. These results support Wegovy's MHRA-licensed indication for weight management in adults with BMI ≥30 or BMI ≥27 with weight-related comorbidities.
Mounjaro's clinical profile stems from the SURMOUNT trial series, showing distinct efficacy patterns due to its dual hormone mechanism. Both medications require clinical assessment to determine individual suitability, as response rates and tolerability profiles vary between patients. Your prescriber will evaluate medical history, current medications, and treatment goals when considering switching from Wegovy to Mounjaro options.
How Wegovy Works For Patients Switching From Wegovy To Mounjaro
Wegovy (semaglutide) functions as a GLP-1 receptor agonist, mimicking the natural incretin hormone that regulates appetite and food intake. The medication binds to GLP-1 receptors in the brain's appetite control centres, promoting feelings of fullness after smaller meals and potentially reducing food cravings. This mechanism supports weight management by naturally decreasing caloric intake when combined with lifestyle modifications. Unlike rapid-acting appetite suppressants, Wegovy provides sustained appetite regulation through once-weekly FlexTouch pen injections. The gradual dose escalation from 0.25mg to 2.4mg allows patients to develop tolerance whilst achieving therapeutic blood levels. Clinical studies indicate that Wegovy may also slow gastric emptying, contributing to prolonged satiety between meals.
Streamlined Ordering Process For Switching From Wegovy To Mounjaro Comparisons
EverydayMeds simplifies the prescription process whether you're continuing Wegovy or exploring Mounjaro alternatives through our comprehensive online platform. The clinical assessment takes approximately 3 minutes to complete, covering medical history, current medications, weight management goals, and previous treatment experiences. Our qualified prescribers review applications within 3 working days (or 24 hours with express processing), ensuring thorough evaluation before approval. Once prescribed, all medications ship via next-day delivery using specialised cold-chain packaging that maintains required 2-8°C storage temperatures. This process includes automatic temperature monitoring and delivery confirmation, guaranteeing medication integrity from our GPhC-registered pharmacy (#9012878) to your door. Patient support continues throughout treatment with clinical queries handled by our qualified team.
Storage and Practical Considerations When Switching From Wegovy To Mounjaro
Wegovy offers superior storage flexibility compared to Mounjaro, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, whilst Mounjaro maintains stability for only 21 days. This advantage proves valuable for travel, work schedules, or situations where refrigeration access becomes limited. The FlexTouch pen system delivers precise doses through a simple click-count mechanism, with each pen containing 4 weekly injections. Dose escalation follows a mandatory 16-week schedule: 0.25mg for weeks 1-4, 0.5mg for weeks 5-8, 1mg for weeks 9-12, 1.7mg for weeks 13-16, then 2.4mg maintenance from week 17 onwards. Injection sites should rotate between thigh, abdomen, or upper arm areas to prevent lipodystrophy, with the same body region used consistently for each weekly injection.
Cost-Effectiveness Analysis For Switching From Wegovy To Mounjaro In The UK Market
Budget planning becomes crucial when comparing long-term treatment costs, as both medications require ongoing use for sustained weight management benefits. EverydayMeds provides cost transparency through clearly structured pricing tiers, allowing accurate treatment cost calculations over 6, 12, or 24-month periods. Our bundle pricing offers convenience rather than savings, with options like the Intro Trio providing seamless dose progression without multiple orders.
The total cost of ownership includes not just medication pricing but also consultation fees, delivery charges, and ongoing clinical support - all incorporated into our single transparent pricing structure. This approach eliminates hidden costs often associated with weight management clinics or traditional GP prescribing routes. When evaluating switching from Wegovy to Mounjaro, patients should consider both immediate monthly costs and long-term treatment sustainability within their healthcare budgets.
Making Your Decision: Switching From Wegovy To Mounjaro With EverydayMeds
Both Wegovy and Mounjaro are available from EverydayMeds, ensuring continuity of care whether you choose to switch treatments or continue your current prescription. Our clinical team provides unbiased guidance based on your individual medical profile, treatment response, and personal preferences rather than promoting specific medications. Remember to use discount codes FIRST40 (new customers) or DOSE25 (returning customers) at checkout to access our competitive pricing structure. Start your clinical assessment today at https://everydaymeds.co.uk/collections/wegovy to explore your options with the UK's most transparent prescription weight management service. This prescription-only medicine requires professional assessment, but our streamlined process ensures quick access to expert clinical evaluation and next-day treatment delivery.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
